Pharmacotherapy of alcoholism – an update on approved and off-label medications

@article{Soyka2017PharmacotherapyOA,
  title={Pharmacotherapy of alcoholism – an update on approved and off-label medications},
  author={M. Soyka and C. Mueller},
  journal={Expert Opinion on Pharmacotherapy},
  year={2017},
  volume={18},
  pages={1187 - 1199}
}
  • M. Soyka, C. Mueller
  • Published 2017
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • ABSTRACT Introduction: Only a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Alcohol Use Disorders (AUD's) are a major health and social problem. Relapse is a rule rather than an exception in alcohol dependence, leading to poor outcomes. Craving are frequently… Expand
    ConditionsAlcohol Use Disorder
    InterventionDevice
    Pharmacogenetics of alcohol use disorder treatments: an update
    • 6
    Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
    • 7
    • PDF
    New steps for treating alcohol use disorder
    • 13
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 235 REFERENCES
    Current pharmacological treatment approaches for alcohol dependence
    • 58
    • PDF
    The Status of Disulfiram: A Half of a Century Later
    • 266
    Neuropharmacological treatments for alcoholism: scientific basis and clinical findings
    • 159